Skip to content
DataLookout
Menu

MINSTNCT07928752

Effects of Adjunctive Melatonin Gel in Type II Diabetics With Stage III-IV Periodontitis

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Clinical Attachment Level (CAL)
Timeframe: from enrollment to 4 weeks then to the end of the study at 8 weeks

Secondary (7)

Probing Pocket Depth (PPD)
Full mouth plaque score (FMPS)
Full mouth bleeding score (FMBS)
GCF Galectin-3
GCF Interleukin 1
Show 2 moreShow less
Serum glycemic level
Patient satisfaction

Arms and interventions

MINST + Melatonin GelExperimental

Participants will receive minimally invasive non-surgical periodontal therapy (MINST), followed by adjunctive subgingival application of 5% melatonin gel into selected periodontal pockets using a syringe equipped with a suitable cannula, once weekly for four consecutive weeks.

MINST AloneActive comparator

Participants will receive minimally invasive non-surgical periodontal therapy (MINST) alone, without adjunctive melatonin gel.

Procedures: Minimally Invasive Non-Surgical Periodontal Therapy (MINST), 5% Melatonin Gel

Sites

1 site in 1 country

  • Badr University in CairoNew Cairo, Cairo Governorate, Egypt